Phase 3 trials of Tapinarof cream for plaque psoriasis.
16 Dec, 2021 | 08:49h | UTCPhase 3 Trials of Tapinarof Cream for Plaque Psoriasis – New England Journal of Medicine
Commentary: Topical tapinarof reduces severity of plaque psoriasis – HealthDay
Commentary on Twitter
In two trials of treatment for psoriasis with the topical aryl hydrocarbon receptor–modulating agent tapinarof, clearance of lesions occurred in a larger proportion of patients who used tapinarof cream than of those who used placebo. https://t.co/I4zgVFELhz pic.twitter.com/qT6lbaJK0U
— NEJM (@NEJM) December 10, 2021